 |
|
Hypopharyngeal Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of hypopharyngeal cancer.
Laryngeal Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of laryngeal cancer.
Lip and Oral Cavity Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of lip and oral cavity cancer.
Metastatic Squamous Neck Cancer with Occult Primary Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of metastatic squamous neck cancer with occult primary.
Nasopharyngeal Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of nasopharyngeal cancer.
Oropharyngeal Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of oropharyngeal cancer.
Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of paranasal sinus and nasal cavity cancer.
Salivary Gland Cancer Treatment (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about the treatment of salivary gland cancer.
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.
Cetuximab (Erbitux®) Plus Radiation Beneficial for Patients with Head and Neck Cancer
Compared to radiation alone, cetuximab plus radiation therapy can nearly double the median survival in patients with a certain kind of head and neck cancer that has not spread to other parts of the body, according to the Feb. 9, 2006, issue of the New England Journal of Medicine.
Docetaxel (Taxotere®) Before Radiation Extends Survival in Patients with Head and Neck Cancer
In a phase III study of patients with inoperable head and neck cancer, a multidrug chemotherapy regimen including the drug docetaxel (Taxotere®) that was given before radiation extended patients' survival by about four months, with fewer side effects, compared to standard therapy.
Angiogenesis Inhibitors Therapy
A fact sheet that describes the process of eliminating the blood supply to tumors. Lists the cancers in which this approach is being tested. National Cancer Institute Fact Sheet 7.42
Photodynamic Therapy for Cancer: Questions and Answers
A fact sheet that explains photodynamic therapy, how it is administered, and indications and side effects of treatment. National Cancer Institute Fact Sheet 7.7
Lasers in Cancer Treatment: Questions and Answers
A fact sheet that describes use of high-intensity light in cancer treatment, its advantages and disadvantages, and types of procedures that use it. National Cancer Institute Fact Sheet 7.8
Metastatic Cancer: Questions and Answers
A fact sheet about metastasis, the spread of cancer to other parts of the body. Discusses the diagnosis and treatment of cancer that has spread. National Cancer Institute Fact Sheet 6.20
Radiation Therapy for Cancer: Questions and Answers
A fact sheet that defines the different types of radiation therapy and discusses scientific advances that improve the effectiveness of this treatment. National Cancer Institute Fact Sheet 7.1
Radiation Therapy and You: Support for People With Cancer
Information about what to expect during radiation therapy, including the general effects of treatment and how to deal with specific side effects.
|
|
|
